Device Generators

Smartablatetm System Rf Generator

Payments companies reported to CMS as associated with Smartablatetm System Rf Generator. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$112Kassociated payments (2023-2025)
246clinicians with associated payments
2companies reporting

By year

2023 $9,351
2024 $65K
2025 $38K

Payments reported as associated with Smartablatetm System Rf Generator, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $77K
Diagnostic Radiology $13K
Neuroradiology $9,438
Surgery $2,631
Gastroenterology (Internal Medicine) $2,065
Colon & Rectal Surgery $1,440

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Smartablatetm System Rf Generator

These are the largest totals companies reported as associated with Smartablatetm System Rf Generator. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Peem Lorvidhaya Fredericksburg, VA Clinical Cardiac Electrophysiology $64,906.00
Mohammad Rahman Pittsburgh, PA Diagnostic Radiology $12,000.00
Christopher Filippi Burlington, VT Neuroradiology $9,300.00
Alexei Shvilkin South Weymouth, MA Clinical Cardiac Electrophysiology $4,995.00
Naveen Narahari Raleigh, NC Gastroenterology (Internal Medicine) $2,065.00
Bruce Koplan Boston, MA Clinical Cardiac Electrophysiology $1,840.00
Steven Furer Springfield, NJ Clinical Cardiac Electrophysiology $1,800.00
Ferdinand Hui Honolulu, HI Diagnostic Radiology $1,080.00
Stuart Jacobson Vancouver, WA Cardiovascular Disease $330.00
Satish Tiyyagura Fair Lawn, NJ Cardiovascular Disease $258.80

Prescribed Smartablatetm System Rf Generator?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.